<?xml version="1.0" encoding="utf-8" standalone="yes"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Mid-cap stocks on FinanClub</title>
    <link>https://finan.club/tags/mid-cap-stocks/</link>
    <description>Recent content in Mid-cap stocks on FinanClub</description>
    <generator>Hugo -- gohugo.io</generator>
    <language>en-us</language>
    <lastBuildDate>Fri, 22 Mar 2024 09:03:29 +0000</lastBuildDate><atom:link href="https://finan.club/tags/mid-cap-stocks/index.xml" rel="self" type="application/rss+xml" />
    <item>
      <title>MRVI</title>
      <link>https://finan.club/us/mrvi/</link>
      <pubDate>Fri, 22 Mar 2024 09:03:29 +0000</pubDate>
      
      <guid>https://finan.club/us/mrvi/</guid>
      <description>score:7
Chances: Maravai LifeSciences has reported strong gains in the mid-cap segment, fueled by confidence about an economic soft landing and a dovish flip by the Fed. Risks: Full year revenue has declined as the company adjusts to post-pandemic demand, indicating potential challenges in the current market environment.</description>
    </item>
    
  </channel>
</rss>
